Skip to main content
. 2023 Sep 13;28(18):6606. doi: 10.3390/molecules28186606

Figure 1.

Figure 1

(A) Representative structures of quinazolinone derivatives as anticancer agents previously reported. (B) Some biologically active molecules containing a pyrazolo-[1,5-c]quinazolinone skeleton. (C) The design idea and synthesis strategy of the pyrazolo-[1,5-c]quinazolinone skeleton.